Showing results (121-130 of 204) with videos related to
Sort By:
Pageof 21
Headache|August 27, 2017
Economics of Inhaled Oxygen Use as an Acute Therapy for Cluster Headache in the United States of AmericaMegan O'Brien, Janet H Ford, Sheena K Aurora, et al.Headache|June 24, 2004
Patterns of use of triptans and reasons for switching them in a tertiary care migraine populationFred D Sheftell, Michele Feleppa, Stewart J Tepper, et al.Headache|June 24, 2022
Migraine treatment with external concurrent occipital and trigeminal neurostimulation-A randomized controlled trialStewart J Tepper, Brian Grosberg, Oved Daniel, et al.Headache|March 13, 2019
Patient Preferences for Preventive Migraine Treatments: A Discrete-Choice ExperimentCarol Mansfield, David J Gebben, Jessie Sutphin, et al.International Journal of Environmental Research and Public Health|January 5, 2021
Mapping Assessments Instruments for Headache Disorders against the ICF Biopsychosocial Model of Health and DisabilityDomenico D'Amico, Stewart J Tepper, Erika Guastafierro, et al.The Journal of Headache and Pain|November 21, 2023
Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trialMessoud Ashina, Stewart J Tepper, Astrid Gendolla, et al.The Journal of Headache and Pain|April 20, 2021
Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database studyStewart J Tepper, Juanzhi Fang, Pamela Vo, et al.Scientific Reports|March 25, 2022
Phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine (TEAM)Deena E Kuruvilla, Joseph I Mann, Stewart J Tepper, et al.Headache|June 11, 2014
Treatment persistence and switching in triptan users: a systematic literature reviewAndrew J Messali, Mo Yang, Patrick Gillard, et al.Patient Preference and Adherence|October 2, 2018
Comparison between prefilled syringe and autoinjector devices on patient-reported experiences and pharmacokinetics in galcanezumab studiesVirginia L Stauffer, Ryan Sides, Michel Lanteri-Minet, et al.Pageof 21